![Robert Tressler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Tressler
Geen lopende functies
Profiel
Robert Tressler worked as an Executive Director of Preclinical Research at Geron Corp., an Associate Director of Pharmacology at CHIRON Biopharmaceuticals, a Senior Director of Pharmacology at Matrix Pharmaceuticals, a Principal at Ligand Pharmaceuticals, a Vice President of Research and Development at Cellerant Therapeutics, and a Principal at Syntex, Inc. He holds a doctorate degree from The University of Texas at Austin and a graduate degree from McNeese State University.
Eerdere bekende functies van Robert Tressler
Bedrijven | Functie | Einde |
---|---|---|
CHIRON Biopharmaceuticals | Corporate Officer/Principal | - |
LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Syntex, Inc. | Corporate Officer/Principal | - |
Matrix Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
GERON CORPORATION | Corporate Officer/Principal | - |
Opleiding van Robert Tressler
McNeese State University | Graduate Degree |
The University of Texas at Austin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GERON CORPORATION | Health Technology |
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Matrix Pharmaceuticals, Inc. | |
Syntex, Inc. | Miscellaneous |
CHIRON Biopharmaceuticals |